|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1993-11-5
|
|
pubmed:abstractText |
In a prospective multicenter study, we analyzed the benefits of allogeneic bone marrow transplantation (BMT) in a nonselected group of adult patients with acute lymphoblastic leukemia (ALL) and, by a randomized trial, evaluated the effectiveness of autologous BMT over chemotherapy as postremission therapy in patients younger than 50 years who were not candidates for allogeneic BMT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1990-2001
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8410124-Adolescent,
pubmed-meshheading:8410124-Adult,
pubmed-meshheading:8410124-Antineoplastic Agents,
pubmed-meshheading:8410124-Bone Marrow Transplantation,
pubmed-meshheading:8410124-Combined Modality Therapy,
pubmed-meshheading:8410124-Female,
pubmed-meshheading:8410124-Humans,
pubmed-meshheading:8410124-Male,
pubmed-meshheading:8410124-Middle Aged,
pubmed-meshheading:8410124-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:8410124-Prospective Studies,
pubmed-meshheading:8410124-Remission Induction,
pubmed-meshheading:8410124-Survival Analysis,
pubmed-meshheading:8410124-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.
|
|
pubmed:affiliation |
Service d'Hématologie, Hôpital Edouard-Herriot, Lyon, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
